Lam Research (LRCX) Posts Record Q4 Results, Issues Guidance Well Above Consensus
Key Takeaways
- •Lam Research reported fiscal fourth-quarter revenue of $6.72 billion, representing 30% year-over-year growth and beating analyst estimates of $6.67 billion.
- •The company's Q1 fiscal 2027 revenue guidance of $7.70 to $8.50 billion far exceeded the Wall Street consensus of $7.09 billion, signaling accelerating tool orders tied to AI-driven demand.
- •CEO Tim Archer attributed the record quarterly performance to AI-related demand that is reshaping the semiconductor equipment industry across leading-edge logic and memory segments.
- •Institutional investors hold 84.61% of LRCX shares, with firms including Eldred Rock Partners, Rokos Capital Management, and Aware Super adding to or establishing positions in recent quarters.
- •Analysts maintain a consensus Moderate Buy rating on LRCX with an average price target of $358.47, while peers such as Applied Materials, ASML, and KLA have also reported above-consensus results, reinforcing a broad AI-linked equipment upturn.

Lam Research (LRCX) gained approximately 1.42% to close at $310.10 on Friday, buoyed by broad strength across the technology sector. The Nasdaq rose 1.12% and the S&P 500 added 0.63%, with technology stocks leading the market, up 1.20%. Eight of the eleven S&P 500 sectors finished higher, with advancing issues outpacing decliners by roughly 2.7 to one.
Friday's move was driven primarily by the broader market rally rather than any new company-specific developments. However, the stock has continued to draw momentum from its fiscal fourth-quarter earnings report released on July 29.
Record Fourth-Quarter Performance
Lam reported Q4 revenue of $6.72 billion, surpassing analyst estimates of $6.67 billion and representing 30% year-over-year growth. Adjusted earnings per share came in at $1.82, beating the $1.68 consensus. Gross margin stood at 51.7%, while operating margin reached 37.4%. The company ended the quarter with $5.6 billion in cash, cash equivalents, and restricted cash.
CEO Tim Archer said the company delivered "record revenue, operating margin and earnings per share" in the June quarter, attributing the performance to AI-driven demand that is reshaping the chipmaking equipment industry. Lam Research is one of the world's largest suppliers of wafer fabrication equipment, specializing in etch and deposition systems used to pattern and build transistor structures at advanced nodes. As chipmakers such as TSMC, Samsung, and SK Hynix ramp production of accelerators for AI training and inference, demand for new deposition and etch tools has intensified across leading-edge logic and memory segments.
Q1 Guidance Far Exceeds Wall Street Expectations
Lam's forward guidance drew significant attention. The company projected Q1 fiscal 2027 revenue of $7.70 billion to $8.50 billion, well above the $7.09 billion consensus among Wall Street analysts. EPS guidance of $2.00 to $2.30 also topped the $1.83 consensus estimate. Analysts currently expect the company to report full-year EPS of $9.24 for the current fiscal year. Lam's fiscal year ends in late June, meaning the guided quarter covers the July–September 2025 period, typically a peak spending season as memory and logic customers install capacity for the following calendar year.
The guidance implies quarter-over-quarter revenue growth of roughly 15–26% at the midpoint, a pace that reflects accelerating tool orders rather than a single-quarter spike. Semiconductor equipment spending is historically cyclical, and the magnitude of Lam's outlook signals that foundry and memory customers are entering a renewed investment phase tied to high-bandwidth memory and advanced packaging capacity.
Institutional Ownership Remains Elevated
Institutional investors and hedge funds hold 84.61% of LRCX shares. Eldred Rock Partners increased its position by 6.4% during the second quarter, purchasing an additional 4,289 shares to bring its total holdings to 71,251. That position is now valued at approximately $30.9 million and represents 6.6% of the firm's portfolio.
Several other institutions have also added to their positions in recent quarters. Rokos Capital Management raised its stake by 42% in Q1, and Aware Super established a new position worth approximately $60 million.
On the insider side, two directors sold shares under pre-arranged Rule 10b5-1 trading plans. Director Eric Brandt sold 54,500 shares at $350.80 in June, and Director Abhijit Talwalkar sold 18,282 shares at $335.00 in July. Total insider sales over the trailing 90 days reached 80,441 units valued at approximately $27.6 million.
Technical Picture and Analyst Ratings
LRCX has traded within a 52-week range of $94.11 to $438.50. The stock currently sits approximately 26% above its 200-day moving average but remains roughly 8.5% below its 50-day moving average. The relative strength index (RSI) stands at 48, indicating neutral momentum. Key support is located near $298.50, close to the 100-day moving average.
On the analyst front, Morgan Stanley maintained an Overweight rating but reduced its price target to $367. Wells Fargo and B. Riley both maintained positive ratings with targets of $350. Mizuho rates the stock Outperform with a $400 target. The consensus average price target across analysts sits at $358.47, reflecting a "Moderate Buy" rating. Among Lam's closest peers, Applied Materials, ASML, KLA Corporation, and Tokyo Electron have also reported or guided above consensus in recent cycles, reinforcing the breadth of the AI-linked equipment upturn.
LRCX closed Friday at $310.10, up 1.42%.